Magrolimab (anti-CD47) | Immunology & Inflammation related | Read Reviews & Product Use Citations

Magrolimab (anti-CD47) (5F9, GS-4721,Hu5F9 G4,ONO 7913) is a first-in-class macrophage immune checkpoint inhibitor that mainly binds to N-terminal pyroglutamate of CD47.

Click to purchase the isotype control of Magrolimab (anti-CD47)

Selleck's Magrolimab (anti-CD47) has been cited by 0 Publication

1 Customer Review

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 7.31mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description	Magrolimab (anti-CD47) (5F9, GS-4721,Hu5F9 G4,ONO 7913) is a first-in-class macrophage immune checkpoint inhibitor that mainly binds to N-terminal pyroglutamate of CD47.

References
[1] Bo Huang, et al. Comput Struct Biotechnol J . 2021 Oct 1;19:5494-5503.

References

[1] Bo Huang, et al. Comput Struct Biotechnol J . 2021 Oct 1;19:5494-5503.

Product Details

CAS No.	2169232-81-7
Molecular Weight	146 KD
Isotype	Human IgG4
Application	Magrolimab (anti-CD47)
Source	CHO cells
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field